Aspirin use is associated with improved postoperative prognosis in patients with stage I-III colorectal cancer after curative resection, particularly those with advanced-stage disease.
Does aspirin improve postoperative prognosis in patients with stage I-III colorectal cancer after curative resection?
Aspirin use may improve postoperative prognosis and prevent recurrence in patients with stage I-III colorectal cancer following curative resection.
This study suggests that aspirin use is associated with improved postoperative prognosis in patients with stage I-III colorectal cancer after curative resection. Aspirin may be beneficial for advanced-stage patients, for whom postoperative adjuvant chemotherapy is recommended.
Bekki et al. (2026) studied this question. Aspirin use is associated with improved postoperative prognosis in patients with stage I-III colorectal cancer after curative resection, particularly those with advanced-stage disease.